Brain metastases

Handbook of Clinical Neurology

Volumn 121, Issue , 2014, Pages 1143-1157

  Gállego Pérez Larraya, Jaime ^a,b   Hildebrand, Jerzy ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brain metastases; Cancer; Chemotherapy; Neurological complication; Radiotherapy; Surgery

Indexed keywords

ARTICLE; BRAIN METASTASES; BRAIN TUMOR; CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; HUMAN; INCIDENCE; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; NEUROLOGICAL COMPLICATION; NEUROSURGERY; PATHOLOGY; PATHOPHYSIOLOGY; RADIOTHERAPY; SURGERY;

BRAIN METASTASES; CANCER; CHEMOTHERAPY; NEUROLOGICAL COMPLICATION; RADIOTHERAPY; SURGERY;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; NEOPLASM METASTASIS; NEUROSURGICAL PROCEDURES;

EID: 84890815463     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4088-7.00077-8     Document Type: Chapter

References (106)

1. Albiges L., Andre F., Balleyguier C., et al. Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann Oncol 2005, 16:1846-1847.
2. Amer M.H., Al-Sarraf M., Baker L.H., et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660-668.
3. Ampil F.L., Nanda A., Willis B.K., et al. Metastatic disease in the cerebellum. The LSU experience in 1981-1993. Am J Clin Oncol 1996, 19:509-511.
4. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
5. Antonadou D., Paraskevaidis M., Sarris G., et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002, 20:3644-3650.
6. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
7. Argyriou A.A., Chroni E., Polychronopoulos P., et al. Headache characteristics and brain metastases prediction in cancer patients. Eur J Cancer Care 2006, 15:90-95.
8. Arseni C. Two hundred and one cases of intracranial tuberculoma treated surgically. J Neurol Neurosurg Psychiatry 1958, 21:308-311.
9. Auperin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999, 341:476-484.
10. Bartsch R., Rottenfusser A., Wenzel C., et al. Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. J Neurooncol 2007, 85:311-317.
11. Baumert B.G., Rutten I., Hing-Oberije C., et al. A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2006, 66:187-194.
12. Becher M.W., Abel T.W., Thompson R.C., et al. Immunohistochemical analysis of metastatic neoplasms of the central nervous system. J Neuropathol Exp Neurol 2006, 65:935-944.
13. Besse B., Lasserre S.F., Compton P., et al. Bevacizumab safety in patients with central nervous system metastases. Clin Cancer Res 2010, 16:269-278.
14. Blitshteyn S., Jaeckle K.A. Nonconvulsive status epilepticus in metastatic CNS disease. Neurology 2006, 66:1261-1263.
15. Borgelt B., Gelber R., Kramer S., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6:1-9.
16. Bremnes R.M., Veve R., Hirsch F.R., et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002, 36:115-124.
17. Cairncross J.G., Kim J.H., Posner J.B. Radiation therapy for brain metastases. Ann Neurol 1980, 7:529-541.
18. Cappuzzo F., Ardizzoni A., Soto-Parra H., et al. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). Lung Cancer 2003, 41:227-231.
19. Chang Y.S., Di Tomaso E., McDonald D.M., et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000, 97:14608-14613.
20. Chang E.L., Wefel J.S., Maor M.H., et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007, 60:277-283.
21. Chang E.L., Wefel J.S., Hess K.R., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
22. Chiang A.C., Massague J. Molecular basis of metastasis. N Engl J Med 2008, 359:2814-2823.
23. DeAngelis L.M., Posner J.B. Intracranial metastases. Neurologic Complications of Cancer 2009, 141-193. Oxford University Press, New York. L.M. DeAngelis, J.B. Posner (Eds.).
24. Deeken J.F., Loscher W. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 2007, 13:1663-1674.
25. Delattre J.Y., Krol G., Thaler H.T., et al. Distribution of brain metastases. Arch Neurol 1988, 45:741-744.
26. Diener-West M., Dobbins T.W., Phillips T.L., et al. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 1989, 16:669-673.
27. Drappatz J., Schiff D., Kesari S., et al. Medical management of brain tumor patients. Neurol Clin 2007, 25:1035-1071.
28. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
29. Flannery T., Kano H., Niranjan, et al. Stereotactic radiosurgery as a therapeutic strategy for intracranial metastatic prostate carcinoma. J Neurooncol 2010, 96:369-374.
30. Forsyth P.A., Posner J.B. Headaches in patients with brain tumors: a study of 111 patients. Neurology 1993, 43:1678-1683.
31. Forsyth P.A., Weaver S., Fulton D., et al. Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 2003, 30:106-112.
32. Gavrilovic I.T., Posner J.B. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005, 75:5-14.
33. Geijer B., Holtas S. Diffusion-weighted imaging of brain metastases: their potential to be misinterpreted as focal ischaemic lesions. Neuroradiology 2002, 44:568-573.
34. Glantz M.J., Cole B.F., Forsyth P.A., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 54:1886-1893.
35. Guerrieri M., Wong K., Ryan G., et al. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung Cancer 2004, 46:107-111.
36. Hazuka M.B., Kinzie J.J. Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 1988, 15:433-437.
37. Hustinx R., Pourdehnad M., Kaschten B., et al. PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am 2005, 43:35-47.
38. Hwang T.L., Close T.P., Grego J.M., et al. Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 1996, 77:1551-1555.
39. Kaal E.C., Taphoorn M.J., Vecht C.J. Symptomatic management and imaging of brain metastases. J Neurooncol 2005, 75:15-20.
40. Karimi S., Lis E., Gilani S., et al. Nonenhancing brain metastases. J Neuroimaging 2009, 21:1-4.
41. Kebudi R., Ayan I., Gorgun O., et al. Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neurooncol 2005, 71:43-48.
42. Kienast Y., von Baumgarten L., Fuhrmann M., et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 2010, 16:116-122.
43. Kikuchi T., Daigo Y., Ishikawa N., et al. Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray. Int J Oncol 2006, 28:799-805.
44. Knauth M., Forsting M., Hartmann M., et al. MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. AJNR Am J Neuroradiol 1996, 17:1853-1859.
45. Kondziolka D., Patel A., Lunsford L.D., et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
46. Koyfman S.A., Tendulkar R.D., Chao S.T., et al. Stereotactic radiosurgery for single brainstem metastases: the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 2010, 78:409-414.
47. Kristensen C.A., Kristjansen P.E., Hansen H.H. Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J Clin Oncol 1992, 10:1498-1502.
48. Kurtz J.M., Gelber R., Brady L.W., et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981, 7:891-895.
49. Kurup P., Reddy S., Hendrickson F.R. Results of re-irradiation for cerebral metastases. Cancer 1980, 46:2587-2589.
50. Lan X.L., Zhang Y.X., Wu Z.J., et al. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 2008, 63:756-764.
51. Law M., Cha S., Knopp E.A., et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002, 222:715-721.
52. Lee A.Y., Levine M.N. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003, 107:I17-I21.
53. Liotta L.A., Kohn E.C. Cancer's deadly signature. Nat Genet 2003, 33:10-11.
54. Logothetis C.J., Samuels M.L., Trindade A. The management of brain metastases in germ cell tumors. Cancer 1982, 49:12-18.
55. Lopez A.D., Mathers C.D., Ezzati M., et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
56. Lynam L.M., Lyons M.K., Drazkowski J.F., et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 2007, 109:634-638.
57. Madhup R., Kirti S., Bhatt M.L., et al. Letrozole for brain and scalp metastases from breast cancer - a case report. Breast 2006, 15:440-442.
58. Majer M., Samlowski W.E. Management of metastatic melanoma patients with brain metastases. Curr Oncol Rep 2007, 9:411-416.
59. Mandybur T.I. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977, 27:650-655.
60. Marchetti D., Denkins Y., Reiland J., et al. Brain-metastatic melanoma: a neurotrophic perspective. Pathol Oncol Res 2003, 9:147-158.
61. Mehta M.P., Rodrigus P., Terhaard C.H., et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003, 21:2529-2536.
62. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
63. Morita R., Fujimoto A., Hatta N., et al. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J Invest Dermatol 1998, 111:919-924.
64. Mornex F., Thomas L., Mohr P., et al. A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res 2003, 13:97-103.
65. Muacevic A., Kufeld M., Wowra B., et al. Feasibility, safety, and outcome of frameless image-guided robotic radiosurgery for brain metastases. J Neurooncol 2010, 97:267-274.
66. Nath S.K., Lawson J.D., Wang J.Z., et al. Optically-guided frameless linac-based radiosurgery for brain metastases: clinical experience. J Neurooncol 2010, 97:67-72.
67. Nathoo N., Chahlavi A., Barnett G.H., et al. Pathobiology of brain metastases. J Clin Pathol 2005, 58:237-242.
68. Navi B.B., Reichman J.S., Berlin D., et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 2010, 74:494-501.
69. Nielsen S.L., Posner J.B. Brain metastasis localized to an area of infarction. J Neurooncol 1983, 1:191-195.
70. Nieswandt B., Hafner M., Echtenacher B., et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999, 59:1295-1300.
71. Nussbaum E.S., Djalilian H.R., Cho K.H., et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781-1788.
72. Oberndorfer S., Schmal T., Lahrmann H., et al. The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien Klin Wochenschr 2002, 114:911-916.
73. Pasqualini R., Arap W. Profiling the molecular diversity of blood vessels. Cold Spring Harb Symp Quant Biol 2002, 67:223-225.
74. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
75. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
76. Pors H., von Eyben F.E., Sorensen O.S., et al. Longterm remission of multiple brain metastases with tamoxifen. J Neurooncol 1991, 10:173-177.
77. Posner J.B., Chernik N.L. Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:579-592.
78. Postmus P.E., Haaxma-Reiche H., Smit E.F., et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000, 18:3400-3408.
79. Rades D., Kieckebusch S., Haatanen T., et al. Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Int J Radiat Oncol Biol Phys 2008, 70:1319-1324.
80. Roberge D., Petrecca K., El Refae M., et al. Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases. J Neurooncol 2009, 95:95-99.
81. Rosner D., Nemoto T., Lane W.W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986, 58:832-839.
82. Ruda R., Borgognone M., Benech F., et al. Brain metastases from unknown primary tumour: a prospective study. J Neurol 2001, 248:394-398.
83. Rustin G.J., Newlands E.S., Begent R.H., et al. Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 1989, 7:900-903.
84. Sause W.T., Crowley J.J., Morantz R., et al. Solitary brain metastasis: results of an RTOG/SWOG protocol evaluation surgery+RT versus RT alone. Am J Clin Oncol 1990, 13:427-432.
85. Sawaya R., Zuccarello M., Elkalliny M., et al. Postoperative venous thromboembolism and brain tumors. Part I. Clinical profile. J Neurooncol 1992, 14:119-125.
86. Schellinger P.D., Meinck H.M., Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 1999, 44:275-281.
87. Schiff D., DeAngelis L.M. Therapy of venous thromboembolism in patients with brain metastases. Cancer 1994, 73:493-498.
88. Schouten L.J., Rutten J., Huveneers H.A., et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94:2698-2705.
89. Seute T., Leffers P., ten Velde G.P., et al. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 2004, 100:801-806.
90. Shi A.A., Digumarthy S.R., Temel J.S., et al. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?. J Thorac Oncol 2006, 1:205-210.
91. Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357:664-672.
92. Soffietti R., Cornu P., Delattre J.Y., et al. EFNS guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 2006, 13:674-681.
93. Stemmler H.J., Schmitt M., Willems A., et al. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anticancer Drugs 2007, 18:23-28.
94. Stewart D.J., Dahrouge S. Response of brain metastases from breast cancer to megestrol acetate: a case report. J Neurooncol 1995, 24:299-301.
95. Suh J.H. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010, 362:1119-1127.
96. Sze G., Johnson C., Kawamura Y., et al. Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol 1998, 19:821-828.
97. Szeifert G.T., Massager N., DeVriendt D., et al. Observations of intracranial neoplasms treated with gamma knife radiosurgery. J Neurosurg 2002, 97:623-626.
98. Ushio Y., Arita N., Hayakawa T., et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 1991, 28:201-205.
99. van de Pol M., van Aalst V.C., Wilmink J.T., et al. Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated?. J Neurol Neurosurg Psychiatry 1996, 61:321-323.
100. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993, 33:583-590.
101. Vecht C.J., Hovestadt A., Verbiest H.B., et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16mg per day. Neurology 1994, 44:675-680.
102. Verger E., Gil M., Yaya R., et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 2005, 61:185-191.
103. Weissman D.E., Janjan N.A., Erickson B., et al. Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. J Neurooncol 1991, 11:235-239.
104. Wesseling P., von Deimling A., Aldape K.D. Metastatic tumours of the CNS. WHO Classification of Tumours of the Central Nervous System 2007, 248-251. International Agency for Research on Cancer, Lyon. D.N. Louis, H. Ohgaki, O.D. Wiestler (Eds.).
105. Wronski M., Arbit E., McCormick B. Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 1997, 80:1746-1754.
106. Young D.F., Posner J.B., Chu F., et al. Rapid-course radiation therapy of cerebral metastases: results and complications. Cancer 1974, 34:1069-1076.